TR200000133T2 - Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi. - Google Patents

Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi.

Info

Publication number
TR200000133T2
TR200000133T2 TR2000/00133T TR200000133T TR200000133T2 TR 200000133 T2 TR200000133 T2 TR 200000133T2 TR 2000/00133 T TR2000/00133 T TR 2000/00133T TR 200000133 T TR200000133 T TR 200000133T TR 200000133 T2 TR200000133 T2 TR 200000133T2
Authority
TR
Turkey
Prior art keywords
diabetes
thiazolidinedione
diabetic
treatment
insulin secretagogue
Prior art date
Application number
TR2000/00133T
Other languages
English (en)
Turkish (tr)
Inventor
Edwin Buckingham Robin
Alistair Smith Stephen
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200000133T2 publication Critical patent/TR200000133T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
TR2000/00133T 1997-07-18 1998-07-16 Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi. TR200000133T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
TR200000133T2 true TR200000133T2 (tr) 2000-09-21

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00133T TR200000133T2 (tr) 1997-07-18 1998-07-16 Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi.

Country Status (27)

Country Link
EP (1) EP1001784A1 (fr)
JP (1) JP2001510160A (fr)
KR (1) KR20010021952A (fr)
CN (1) CN1263467A (fr)
AP (1) AP2000001735A0 (fr)
AR (2) AR016350A1 (fr)
AU (1) AU8449098A (fr)
BG (1) BG104062A (fr)
BR (1) BR9810292A (fr)
CA (1) CA2297133A1 (fr)
CO (1) CO4940489A1 (fr)
DZ (1) DZ2563A1 (fr)
EA (1) EA200000140A1 (fr)
GB (1) GB9715298D0 (fr)
HU (1) HUP0003626A3 (fr)
ID (1) ID23804A (fr)
IL (1) IL133907A0 (fr)
MA (1) MA24608A1 (fr)
NO (1) NO20000230D0 (fr)
OA (1) OA11312A (fr)
PE (1) PE99499A1 (fr)
PL (1) PL338140A1 (fr)
SK (1) SK612000A3 (fr)
TR (1) TR200000133T2 (fr)
UY (1) UY25101A1 (fr)
WO (1) WO1999003478A1 (fr)
ZA (1) ZA986364B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
EP1849475A1 (fr) 1999-06-21 2007-10-31 Eli Lilly & Company Utilisation synergique des thiazolidinediones avec peptide-1 comme glucagon et agonistes correspondants pour traiter les diabètes non dépendants de l'insuline
EP1743655B1 (fr) * 2000-01-21 2014-06-25 Novartis AG Combinaisons à base d'inhibiteurs de DPP-IV et d'antidiabetiques
WO2001062295A1 (fr) * 2000-02-24 2001-08-30 Takeda Chemical Industries, Ltd. Medicaments contenant des ingredients actifs combines
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
CA2434169C (fr) 2001-01-12 2011-03-15 Sun Pharmaceutical Industries Limited Systeme de liberation espacee de medicaments
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
CA2540225C (fr) 2003-10-31 2012-03-06 Takeda Pharmaceutical Company Limited Preparation solide comprenant du pioglitazone, du glimepiride et un ester d'acide gras de polyoxyethylene sorbitan
CN101103993B (zh) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0601001B1 (fr) * 1991-08-26 1997-04-16 PHARMACIA & UPJOHN COMPANY Composition alimentaire liquide contenant de l'acide 3-guanidinopropionique
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
EA200000140A1 (ru) 2000-06-26
IL133907A0 (en) 2001-04-30
NO20000230L (no) 2000-01-17
WO1999003478A1 (fr) 1999-01-28
OA11312A (en) 2003-10-24
GB9715298D0 (en) 1997-09-24
PL338140A1 (en) 2000-09-25
AP2000001735A0 (en) 2000-01-16
AR019724A2 (es) 2002-03-13
BR9810292A (pt) 2000-09-19
NO20000230D0 (no) 2000-01-17
HUP0003626A2 (hu) 2001-05-28
KR20010021952A (ko) 2001-03-15
CO4940489A1 (es) 2000-07-24
AR016350A1 (es) 2001-07-04
MA24608A1 (fr) 1999-04-01
DZ2563A1 (fr) 2003-02-15
BG104062A (en) 2000-11-30
AU8449098A (en) 1999-02-10
PE99499A1 (es) 1999-12-18
CN1263467A (zh) 2000-08-16
ZA986364B (en) 2000-01-17
CA2297133A1 (fr) 1999-01-28
HUP0003626A3 (en) 2001-12-28
UY25101A1 (es) 2000-12-29
JP2001510160A (ja) 2001-07-31
EP1001784A1 (fr) 2000-05-24
SK612000A3 (en) 2000-07-11
ID23804A (id) 2000-05-11

Similar Documents

Publication Publication Date Title
EA200000041A1 (ru) Способ лечения диабета тиазолидиндионом и метформином
BG105431A (en) METHOD FOR TREATING DIABETES EMPLOYING AN Ap2 INHIBITOR AND COMBINATION
EA200300036A1 (ru) Комбинации ингибиторов дипептидилпептидазы iv и других антидиабетических агентов для лечения сахарного диабета
EA200100541A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов
TR200000133T2 (tr) Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi.
BR0308904A (pt) Método de tratamento de gastroparesia, e, uso de um composto de glp-1
MY155219A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
BR9810444A (pt) Tratamento de diabete com rosiglitazona e insulina
ES2131122T3 (es) Uso de il-10 para prevenir la diabetes mellitus dependiente de insulina.
GB2331988B (en) Polycyclic sulphamate inhibitors or oestrone sulphatase
NO996270L (no) Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor
TR200000135T2 (tr) Tiazolidinedion ve sülfonilüre ile diabet tedavisi.
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
BR9810142A (pt) Tratamento de diabete com tiazolidinadiona e sulfonil-uréia
ES2166406T3 (es) Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina.
ES2181923T3 (es) 4-hidroxicumarin-3-carboxamidas para el tratamiento de la diabet es mellitus no dependiente de la insulina.
ES2135353A1 (es) Utilizacion del 17beta-estradiol, sus analogos y derivados en el tratamiento de la diabetes mellitus y sus manifestaciones.
AU2002319381A1 (en) Use of antidiabetics for making a medicine with cicatrizing effect
EA199800177A1 (ru) Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
IT1295954B1 (it) Utilizzo di un agente chimico per diminuire le variazioni di giro di vita e l'effetto di costipazione legato all'assunzione di altri agenti
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
HK1028551A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor
EA200000419A1 (ru) Применение тиазолидиндионов для лечения гипергликемии
ECSP982541A (es) Nuevo metodo de tratamiento ii
ECSP993146A (es) Metodo de tratameinto para la diabetes empleando un inhibidor ap2 y su combinacion